Unrelated donor bone marrow transplantation for children with acute leukemia

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 557-565

  Davies, S M ^a   Wagner, J E ^a   Shu, X O ^a   Blazar, B R ^a   Katsanis, E ^a   Orchard, P J ^a   Kersey, J H ^a   Dusenbery, K E ^a   Weisdorf, D J ^a   McGlave, P B ^a   Ramsay, N K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; HIGH RISK PATIENT; HLA MATCHING; HUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS;

EID: 18844464929     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.557     Document Type: Article

References (36)

1. Rivera GK, Pinkel D, Simone JV, et al.: Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med 329:1289-1295, 1993
2. Williams DL, Harber J, Murphy SB, et al.: Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia. Blood 68:206-212, 1986
3. Crist W, Carroll A, Shuster J, et al.: Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76:489-494, 1990
4. Pui C-H, Frankel LS, Carroll AJ, et al.: Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4; 11) (q21;q23): A collaborative study of 40 cases. Blood 77:440-447, 1991
5. Reaman G, Zeltzer P, Bleyer WA, et al.: Acute lymphoblastic leukemia in infants less than one year of age: A cumulative experience of the Childrens Cancer Study Group. J Clin Oncol 3:1513-1521, 1985
6. Wells RJ, Woods WG, Buckley JD, et al.: Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Childrens Cancer Group study. J Clin Oncol 12:2367-2377, 1994
7. Stroncek D, Bartsch G, Perkins HA, et al.: The National Marrow Donor Program. Transfusion 33:567-577, 1993
8. Perkins HA, Hansen JA: The U.S. National Marrow Donor Program. Am J Pediatr Hematol Oncol 16:30-34, 1994
9. Operations Manual, National Marrow Donor Program. Minneapolis, MN, University of Minnesota, 1989, pp 6.10-6.12
10. Weisdorf DJ, Woods WG, Nesbit M, et al.: Allogeneic bone marrow transplantation for acute lymphoblastic leukemia. Br J Haematol 86:62-69, 1994
11. Weisdorf DJ, McGlave PB, Ramsay NKC, et al.: Allogeneic bone marrow transplantation for acute leukemia: Comparative outcomes for adults and children. Br J Haematol 69:351-358, 1988
12. Santos GW, Tutschka PJ, Brookmeyer R, et al.: Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309:1347-1353, 1983
13. Deeg HJ, Storb R: Graft-versus-host disease: Pathophysiological and clinical aspects. Annu Rev Med 3:11-24, 1984
14. Weisdorf DJ, Snover DC, Haake R, et al.: Acute upper gastrointestinal graft-versus-host disease: Clinical significance and response to immunosuppressive therapy. Blood 76:624-629, 1990
15. Ramsay NKC, Kersey JH, Robison LL, et al.: A randomized study of the prevention of acute graft-versus-host disease. N Engl J Med 306:392-397, 1982
16. Roy J, McGlave PB, Filipovich AH, et al.: Acute graft-versus-host disease following unrelated donor marrow transplantation: Failure of conventional therapy. Bone Marrow Transplant 10:77-82, 1992
17. Weisdorf D, Filipovich A, McGlave P, et al.: Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation. Bone Marrow Transplant 12:531-536, 1993
18. Storb R, Deeg HJ, Farewell V, et al.: Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host-disease. Blood 68:119-125, 1986
19. Wagner JE, Santos GW, Noga SD, et al.: Bone marrow graft engineering by counterflow centrifugal elutriation: Results of a phase I-II clinical trial. Blood 75:1370-1377, 1990
20. Blazar BR, Orr HT, Arthur DC, et al.: Restriction fragment length polymorphisms as markers of engraftment in allogeneic marrow transplantation. Blood 66:1436-1444, 1985
21. Budowle B, Chakraborty R, Giusti AM, et al.: Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48:137-144, 1991
22. Stroker NG, Cheah KSE, Griffin JR, et al.: A highly polymorphic region 3′ to the human type II collagen gene. Nucl Acids Res 13:4613-4622, 1985
23. Wu S, Seino S, Bell GI: Human collagen, type II, alpha 1, (COL2A1) gene: VNTR polymorphism detected by gene amplification. Nucl Acids Res 18:3102, 1990
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
25. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc [A] 135:185-191, 1972
26. Hogg SA, Ciampi A, Lawless J: GGDMLE: A computer program which finds maximum likelihood estimates for the generalized log gamma distribution. Comput Methods Programs Biomed 15:201-215, 1982
27. Kernan NA, Bartsch G, Ash RC, et al.: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593-602, 1993
28. Davies SM, Ramsay NKC, Weisdorf DJ: Feasibility and timing on unrelated donor identification for patients with ALL. Bone Marrow Transplant 17:737-740, 1996
29. Davies SM, Shu XO, Blazar BR, et al.: Unrelated donor bone marrow transplantation: Influence of HLA A and B incompatibility on outcome. Blood 86:1636-1642, 1995
30. Casper J, Camitta B, Truitt R, et al.: Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia. Blood 85:2354-2363, 1995
31. Davies SM, Ramsay NKC, Haake RJ, et al.: Comparison of engraftment in recipients of matched sibling or unrelated donor marrow allografts. Bone Marrow Transplant 13:51-57, 1994
32. Beatty PG, Anasetti C, Hansen JA, et al.: Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 81:249-253, 1993
33. Balduzzi A, Gooley T, Anasetti C, et al.: Unrelated donor marrow transplantation in children. Blood 86:3247-3256, 1995
34. Ochs L, Shu XO, Miller J, et al.: Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients. Blood 86:3979-3986, 1995
35. Enright H, Davies SM, DeFor T, et al.: Relapse following non-T-cell-depleted allogeneic bone marrow transplant for CML: Early transplant, the use of an unrelated donor and chronic graft-versus-host disease are protective. Blood 88:714-720, 1996
36. Hessner MJ, Endean DJ, Casper JT, et al.: Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell depleted allogeneic marrow transplantation for chronic myelogenous leukemia. Blood 86:3987-3996, 1995